| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5545628 | CIPHER PHARMS INC | Pharmaceutical composition containing fenofibrate |
Jan, 2015
(9 years ago) | |
Lipofen is owned by Cipher Pharms Inc.
Lipofen contains Fenofibrate.
Lipofen has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Lipofen are:
- US5545628
Lipofen was authorised for market use on 11 January, 2006.
Lipofen is available in capsule;oral dosage forms.
Lipofen can be used as treatment of hypercholesterolemia and/or hypertriglyceridemia.
The generics of Lipofen are possible to be released after 10 January, 2015.
Drugs and Companies using FENOFIBRATE ingredient
Market Authorisation Date: 11 January, 2006
Treatment: Treatment of hypercholesterolemia and/or hypertriglyceridemia
Dosage: CAPSULE;ORAL
More Information on Dosage
LIPOFEN family patents
